Recruiting NCT05749588
FUSCC Refractory TNBC Platform Study (FUTURE2.0)
Why this may match: Triple-negative Breast Cancer · Recruiting · China · Phase II
3 trials in this section
Detailed eligibility, including treatment history and laboratory results, still needs to be checked.
Why this may match: Triple-negative Breast Cancer · Recruiting · China · Phase II
Why this may match: Breast Cancer, Endocrine Therapy · Recruiting · China
Why this may match: Breast Cancer · Recruiting · China